The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis

por Pelfrene, Eric, Harvey Allchurch, Martin, Ntamabyaliro, Nsengi, Nambasa, Victoria, Ventura, Fátima V., Nagercoil, Nithyanandan, Cavaleri, Marco
Publicado 2019

Nanopharmaceutics: Part I—Clinical Trials Legislation and Good Manufacturing Practices (GMP) of Nanotherapeutics in the EU

por Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Publicado 2020

Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods

por Souto, Eliana B., Silva, Gabriela F., Dias-Ferreira, João, Zielinska, Aleksandra, Ventura, Fátima, Durazzo, Alessandra, Lucarini, Massimo, Novellino, Ettore, Santini, Antonello
Publicado 2020